Paper2805280
Primary pulmonary hypertension. The risk and benefit of lung biopsy.
Nicod P and 1 other. Circulation, 1989. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Primary pulmonary hypertension. The risk and benefit of lung biopsy. Papers, record 2805280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2805280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension, Pulmonary | Major topic |
| Lung | Major topic |
| Biopsy | |
| Humans |
Source PubMed
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 2344692 | Risk and benefit of lung biopsy in primary pulmonary hypertension. | https://conductscience.org/library/papers/2344692 | PubMed |
| Comment on | 2805258 | Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. | https://conductscience.org/library/papers/2805258 | PubMed |
| Comment on | 2805259 | Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. | https://conductscience.org/library/papers/2805259 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31965379 | Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis. | Clin Rheumatol | 2020 | https://conductscience.org/library/papers/31965379 | PubMed |
| 30568112 | Pulmonary Veno-occlusive Disease: A Surgical Lung Biopsy-proven and Autopsied Case Radiologically Mimicking Hypersensitivity Pneumonitis at the Time of a Transbronchial Lung Biopsy. | Intern Med | 2019 | https://conductscience.org/library/papers/30568112 | PubMed |
| 28466120 | Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management. | Curr Treat Options Cardiovasc Med | 2017 | https://conductscience.org/library/papers/28466120 | PubMed |
| 25076987 | Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates. | Ann Thorac Med | 2014 | https://conductscience.org/library/papers/25076987 | PubMed |
| 23730366 | In vivo assessment of pulmonary arterial wall fibrosis by intravascular optical coherence tomography in pulmonary arterial hypertension: a new prognostic marker of adverse clinical follow-up. | Open Respir Med J | 2013 | https://conductscience.org/library/papers/23730366 | PubMed |
| 11473937 | Recommendations on the management of pulmonary hypertension in clinical practice. | Heart | 2001 | https://conductscience.org/library/papers/11473937 | PubMed |
| 8741230 | The clinical potential of endothelin receptor antagonists in cardiovascular medicine. | Drugs | 1996 | https://conductscience.org/library/papers/8741230 | PubMed |
| 2281438 | Clinical correlates of angiographically diagnosed idiopathic pulmonary hypertension. | Thorax | 1990 | https://conductscience.org/library/papers/2281438 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2805280
GET https://conductscience.org/api/papers/v1/2805280/authors